A Randomized, Double Blind, Placebo-Controlled Trial of Alendronate Treatment for Fibrous Dysplasia of Bone

CONTEXT: Fibrous dysplasia (FD) is a rare skeletal disorder, resulting in deformity, fracture, functional impairment, and pain. Bisphosphonates have been advocated as a potential treatment. OBJECTIVE: To determine the efficacy of alendronate for treatment of FD. DESIGN: Two-year randomized, double-b...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Endocrinol Metab
Autors principals: Boyce, Alison M., Kelly, Marilyn H., Brillante, Beth A., Kushner, Harvey, Wientroub, Shlomo, Riminucci, Mara, Bianco, Paolo, Robey, Pamela G., Collins, Michael T.
Format: Artigo
Idioma:Inglês
Publicat: Endocrine Society 2014
Matèries:
Endocrine Care
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4223439/
https://ncbi.nlm.nih.gov/pubmed/25033066
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2014-1371
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars